Stephen A. Trowbridge - 15 Jul 2022 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
EVP and CFO
Signature
/s/ Richard C. Rosenzweig, Attorney in Fact
Issuer symbol
ANGO
Transactions as of
15 Jul 2022
Net transactions value
-$28,935
Form type
4
Filing time
18 Jul 2022, 16:13:11 UTC
Previous filing
11 Jul 2022
Next filing
22 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Options Exercise $235,390 +14,758 +19% $15.95 92,935 15 Jul 2022 Direct
transaction ANGO Common Stock Tax liability $264,325 -12,398 -13% $21.32 80,537 15 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGO Non- Qualified Stock Option (right to buy) Options Exercise $0 -14,758 -100% $0.000000* 0 15 Jul 2022 Common Stock 14,758 $15.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exempt disposition of 12,398 shares of common stock of AngioDynamics, Inc. (the "Company") to the Company was made to satisfy the exercise price arising from a net (cashless) exercise of stock options that were set to expire on 7/22/2022.
F2 Options for one-fourth of the shares were each exercisable beginning 7/22/2016, 7/22/2017, 7/22/2018 and 7/22/2019, respectively.